Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12

OBJECTIVE: The rarity of large vessel vasculitis (LVV) is a major factor limiting randomized controlled trials in LVV, resulting in treatment choices in these diseases that are guided mainly by observational studies and expert opinion. Further complicating trials in LVV is the absence of validated a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Rheumatol
Main Authors: Aydin, Sibel Zehra, Direskeneli, Haner, Sreih, Antoine, Alibaz-Oner, Fatma, Gul, Ahmet, Kamali, Sevil, Hatemi, Gulen, Kermani, Tanaz, Mackie, Sarah L., Mahr, Alfred, Meara, Alexa, Milman, Nataliya, Nugent, Heidi, Robson, Joanna, Tomasson, Gunnar, Merkel, Peter A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4668221/
https://ncbi.nlm.nih.gov/pubmed/26077399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.141144
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados